Model N, Inc. provides cloud revenue management solutions for life sciences and high-tech companies in the United States and internationally. The company offers Global Pricing Management, which minimizes price erosion of products; Global Tender Management that enhances revenue by enabling segmentation and targeting, optimal bid pricing, and post-award tracking; Provider Management, which minimizes rebate overpayments; Payer Management that minimizes revenue leakage and noncompliance of complex contracts; Government Pricing, which optimizes revenue, and reduces the risk of fines and other penalties; and Medicaid that enhances compliance with regulatory requirements and payments of rebate claims on a timely basis and at correct rates for government Medicaid programs, as well as Validata, State Pricing Transparency Management, Advanced Membership Management, and Intelligence Cloud. It also provides Deal Management, which increases deal conversion and pricing consistency; Deal Intelligence that controls price concessions and determines ideal prices; Channel Management, which provides manufacturers a view of inventory, as well as evaluate price protection and stock rotation, and matching available inventory to quotes; Market Development Fund Management that allows companies to streamline their MDF process and reduce revenue leakage; Rebates Management, which centralizes control of rebate programs; and Channel Data Management that automates the process of collection, cleansing, validation, and standardization of channel partner data, such as POS, inventory, and claims, as well as Payment Management. In addition, the company offers implementation, application, business, strategic, and customer support services. It primarily serves large, mid-sized, and small life sciences and high tech manufactures worldwide through its direct sales force. The company was incorporated in 1999 and is headquartered in Redwood City, California.
Vista's $1.25B Bid | Explore the implications of Vista Equity Partners' acquisition offer for Model N, valuing the company at $30 per share in an all-cash transaction |
Financial Trajectory | Delve into Model N's mixed financial performance, including consistent earnings beats and projected EPS improvement from -$0.87 in FY2023 to $0.10 by FY2026 |
Market Positioning | Learn about Model N's leadership in revenue management solutions for Life Sciences, balanced against its low-growth profile in the broader software secto |
Strategic Outlook | Discover how private ownership could benefit Model N's long-term strategy, potentially accelerating growth and enabling transformational M&A opportunities |